This compound is a spirocyclic benzothiazole derivative in the form of a methanesulfonate salt, used as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients. It features a complex polycyclic structure with a bicyclic octahydroisoindole ring system and a piperazine-like moiety, contributing to its role in medicinal chemistry.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 186204-37-5
(2R,3S,4S)-2,3,4-Tris(benzyloxy)-4-(4-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-methylpiperazin-1-yl)butan-1-one oxalate
pharmaceutical intermediate synthesis
6-bromoisoquinoline
pharmaceutical intermediate synthesis
ETHYL 4,6-DICHLOROPYRIDAZINE-3-CARBOXYLATE
pharmaceutical intermediate synthesis
2,3-dihydro-5-benzofuranacetic acid
pharmaceutical intermediate synthesis
1-(diphenylmethyl)azetidin-3-ol
pharmaceutical intermediate
3-Hydroxyazetidine hydrochloride
pharmaceutical intermediate
2-[(2R)-2,3-Dihydroxypropyl]-1H-isoindole-1,3(2H)-dione
Pharmaceutical intermediate for chiral synthesis
Alloc-Lys(Fmoc)-OH
protected amino acid for peptide synthesis
3-[(3aR,7aR)-spiro[1,3,3a,4,5,6,7,7a-octahydroisoindol-2-ium-2,4'-1,4-diazinan-4-ium]-1'-yl]-1,2-benzothiazole;methanesulfonate
DCZWVXNDLGWVAS-MOGJOVFKSA-M
CS(=O)(=O)[O-].C1CC[C@H]2C[N+]3(CCN(CC3)C4=NSC5=CC=CC=C54)C[C@@H]2C1